Tryptophan catabolism modulator

摘要

Modulator type (I) compound of tryptophan cataract: [Chemical formula 1] and of cancer, immunosuppression, viral infection, depression, neurodegenerative disorder, trauma, age-related cataract, organ transplant refusal, or autoimmune disorder in patients. Their use as pharmaceuticals in the treatment of diseases associated with abnormal or elevated cataracts of tryptophan, such as, has been described.